Analyst Price Targets — VERU
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| May 3, 2024 11:38 am | Yi Chen | H.C. Wainwright | $3.00 | $1.67 | TheFly | Veru price target raised to $3 from $2 at H.C. Wainwright |
| April 15, 2024 5:50 am | Leland Gershell | Oppenheimer | $5.00 | $1.52 | StreetInsider | Veru, Inc. (VERU) PT Lowered to $5 at Oppenheimer |
| December 7, 2022 6:28 am | — | H.C. Wainwright | $18.00 | $5.66 | Benzinga | HC Wainwright & Co. Maintains Buy on Veru, Lowers Price Target to $18 |
| April 15, 2022 11:26 am | Leland Gershell | Oppenheimer | $36.00 | $14.95 | Pulse 2.0 | Veru (VERU) Stock: $36 Price Target And Outperform Rating |
Latest News for VERU
Veru Inc. (VERU) Q1 2026 Earnings Call Transcript
Veru (NASDAQ: VERU - Get Free Report) and Flora Growth (NASDAQ: FLGC - Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, valuation, dividends, risk, profitability and institutional ownership. Earnings and Valuation This table compares Veru and
MIAMI, FL, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced it will host a conference call and audio webcast on Wednesday, February 11, 2026, at 8:00 a.m. ET to discuss its fiscal 2026 first quarter financial results and to provide a…
Veru Inc. (VERU) Q4 2025 Earnings Call Transcript
MIAMI, FL, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced financial results for its fiscal year 2025 ended September 30, 2025 and provided an update on the clinical progress of its obesity program.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for VERU.
U.S. House Trading
No House trades found for VERU.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.